Last 12 months
Inside the activity.
1 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 1 | 1 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 17, 2021 Filed Sep 18, 2021 00:45 UTC |
GARCIA PETER SChief Financial Officer
|
SaleCommon Stock | 1,746 | $79.46 | $138,734.37 |
DisclosureSEC source: 0001209191-21-056787 · doc4.xml · nonDerivative · entry 6 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,704 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.05 to $80.02, inclusive. Read SEC document |
| September 17, 2021 Filed Sep 18, 2021 00:45 UTC |
GARCIA PETER SChief Financial Officer
|
SaleCommon Stock | 7,199 | $78.61 | $565,922.03 |
DisclosureSEC source: 0001209191-21-056787 · doc4.xml · nonDerivative · entry 5 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,450 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.05 to $79.045, inclusive. Read SEC document |
| September 17, 2021 Filed Sep 18, 2021 00:45 UTC |
GARCIA PETER SChief Financial Officer
|
SaleCommon Stock | 1,027 | $77.84 | $79,944.45 |
DisclosureSEC source: 0001209191-21-056787 · doc4.xml · nonDerivative · entry 4 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,649 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.05 to $78.045, inclusive. Read SEC document |
| September 17, 2021 Filed Sep 18, 2021 00:45 UTC |
GARCIA PETER SChief Financial Officer
|
Exercise / conversionCommon Stock | 11,345 | $4.08 | $46,287.60 |
DisclosureSEC source: 0001209191-21-056787 · doc4.xml · nonDerivative · entry 3 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2021 Filed Sep 18, 2021 00:45 UTC |
GARCIA PETER SChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,426 | $0.00 Strike: $4.08 | $0.00 |
DisclosureSEC source: 0001209191-21-056787 · doc4.xml · derivative · entry 9 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,042 Underlying: Common Stock · 1,426 shares Expires 2030-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vest on March 9, 2021 and 1/36th of the remaining shares vest monthly thereafter. Read SEC document |
| September 16, 2021 Filed Sep 18, 2021 00:45 UTC |
GARCIA PETER SChief Financial Officer
|
SaleCommon Stock | 1,426 | $80.43 | $114,694.89 |
DisclosureSEC source: 0001209191-21-056787 · doc4.xml · nonDerivative · entry 2 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,331 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.00 to $80.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (6) to this Form 4. Read SEC document |
| September 16, 2021 Filed Sep 18, 2021 00:45 UTC |
GARCIA PETER SChief Financial Officer
|
Exercise / conversionCommon Stock | 1,426 | $4.08 | $5,818.08 |
DisclosureSEC source: 0001209191-21-056787 · doc4.xml · nonDerivative · entry 1 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,757 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2021 Filed Sep 13, 2021 19:10 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
SaleCommon Stock | 1,458 | $78.31 | $114,182.69 |
DisclosureSEC source: 0001209191-21-055753 · doc4.xml · nonDerivative · entry 3 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,815 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 28, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.07 to $78.86, inclusive. Read SEC document |
| September 10, 2021 Filed Sep 13, 2021 19:10 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
SaleCommon Stock | 5,029 | $77.69 | $390,681.89 |
DisclosureSEC source: 0001209191-21-055753 · doc4.xml · nonDerivative · entry 2 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,273 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 28, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.07 to $78.06, inclusive. Read SEC document |
| September 10, 2021 Filed Sep 13, 2021 19:10 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
SaleCommon Stock | 900 | $76.45 | $68,805.90 |
DisclosureSEC source: 0001209191-21-055753 · doc4.xml · nonDerivative · entry 1 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,302 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 28, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.03 to $76.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Read SEC document |
| August 23, 2021 Filed Aug 24, 2021 22:17 UTC |
GARCIA PETER SChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 19,370 | $0.00 Strike: $4.08 | $0.00 |
DisclosureSEC source: 0001209191-21-053218 · doc4.xml · derivative · entry 11 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,468 Underlying: Common Stock · 19,370 shares Expires 2030-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vest on March 9, 2021 and 1/36th of the remaining shares vest monthly thereafter. Read SEC document |
| August 23, 2021 Filed Aug 24, 2021 22:17 UTC |
GARCIA PETER SChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 40,630 | $0.00 Strike: $4.08 | $0.00 |
DisclosureSEC source: 0001209191-21-053218 · doc4.xml · derivative · entry 10 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,659 Underlying: Common Stock · 40,630 shares Expires 2030-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vested on January 2, 2021 and 1/36th of the remaining shares vest monthly thereafter. Read SEC document |
| August 23, 2021 Filed Aug 24, 2021 22:17 UTC |
GARCIA PETER SChief Financial Officer
|
SaleCommon Stock | 35 | $77.56 | $2,714.63 |
DisclosureSEC source: 0001209191-21-053218 · doc4.xml · nonDerivative · entry 9 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,331 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.46 to $77.79, inclusive. Read SEC document |
| August 23, 2021 Filed Aug 24, 2021 22:17 UTC |
GARCIA PETER SChief Financial Officer
|
SaleCommon Stock | 2,616 | $76.66 | $200,549.88 |
DisclosureSEC source: 0001209191-21-053218 · doc4.xml · nonDerivative · entry 8 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,366 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.31 to $77.27, inclusive. Read SEC document |
| August 23, 2021 Filed Aug 24, 2021 22:17 UTC |
GARCIA PETER SChief Financial Officer
|
SaleCommon Stock | 10,743 | $75.71 | $813,317.08 |
DisclosureSEC source: 0001209191-21-053218 · doc4.xml · nonDerivative · entry 7 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,982 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.31 to $76.295, inclusive. Read SEC document |
| August 23, 2021 Filed Aug 24, 2021 22:17 UTC |
GARCIA PETER SChief Financial Officer
|
SaleCommon Stock | 19,448 | $75.09 | $1,460,278.36 |
DisclosureSEC source: 0001209191-21-053218 · doc4.xml · nonDerivative · entry 6 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,725 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.31 to $75.305, inclusive. Read SEC document |
| August 23, 2021 Filed Aug 24, 2021 22:17 UTC |
GARCIA PETER SChief Financial Officer
|
SaleCommon Stock | 4,008 | $73.57 | $294,871.37 |
DisclosureSEC source: 0001209191-21-053218 · doc4.xml · nonDerivative · entry 5 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,173 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.30 to $74.295, inclusive. Read SEC document |
| August 23, 2021 Filed Aug 24, 2021 22:17 UTC |
GARCIA PETER SChief Financial Officer
|
SaleCommon Stock | 18,060 | $72.66 | $1,312,252.24 |
DisclosureSEC source: 0001209191-21-053218 · doc4.xml · nonDerivative · entry 4 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,181 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.275 to $73.265, inclusive. Read SEC document |
| August 23, 2021 Filed Aug 24, 2021 22:17 UTC |
GARCIA PETER SChief Financial Officer
|
SaleCommon Stock | 3,497 | $72.03 | $251,906.05 |
DisclosureSEC source: 0001209191-21-053218 · doc4.xml · nonDerivative · entry 3 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,241 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.27 to $72.265, inclusive. Read SEC document |
| August 23, 2021 Filed Aug 24, 2021 22:17 UTC |
GARCIA PETER SChief Financial Officer
|
SaleCommon Stock | 1,593 | $70.86 | $112,872.17 |
DisclosureSEC source: 0001209191-21-053218 · doc4.xml · nonDerivative · entry 2 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,738 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.27 to $71.26, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (9) to this Form 4. Read SEC document |
| August 23, 2021 Filed Aug 24, 2021 22:17 UTC |
GARCIA PETER SChief Financial Officer
|
Exercise / conversionCommon Stock | 60,000 | $4.08 | $244,800.00 |
DisclosureSEC source: 0001209191-21-053218 · doc4.xml · nonDerivative · entry 1 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2021 Filed Aug 20, 2021 20:07 UTC |
Pons JaumeDirector · President & CEO
|
SaleCommon Stock | 617 | $66.24 | $40,871.50 |
DisclosureSEC source: 0001209191-21-052864 · doc4.xml · nonDerivative · entry 7 Pons Jaume · CIK 0001816977 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 477,998 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 28, 2021. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.86 to $66.845, inclusive. Read SEC document |
| August 19, 2021 Filed Aug 20, 2021 20:07 UTC |
Pons JaumeDirector · President & CEO
|
SaleCommon Stock | 1,373 | $65.60 | $90,073.74 |
DisclosureSEC source: 0001209191-21-052864 · doc4.xml · nonDerivative · entry 6 Pons Jaume · CIK 0001816977 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 478,615 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 28, 2021. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.87 to $65.85, inclusive. Read SEC document |
| August 19, 2021 Filed Aug 20, 2021 20:07 UTC |
Pons JaumeDirector · President & CEO
|
SaleCommon Stock | 556 | $64.22 | $35,706.38 |
DisclosureSEC source: 0001209191-21-052864 · doc4.xml · nonDerivative · entry 5 Pons Jaume · CIK 0001816977 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 479,988 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 28, 2021. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.63 to $64.625, inclusive. Read SEC document |
| August 19, 2021 Filed Aug 20, 2021 20:07 UTC |
Pons JaumeDirector · President & CEO
|
SaleCommon Stock | 1,190 | $62.84 | $74,784.48 |
DisclosureSEC source: 0001209191-21-052864 · doc4.xml · nonDerivative · entry 4 Pons Jaume · CIK 0001816977 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 480,544 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 28, 2021. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.46 to $63.34, inclusive. Read SEC document |
| August 19, 2021 Filed Aug 20, 2021 20:07 UTC |
Pons JaumeDirector · President & CEO
|
SaleCommon Stock | 1,324 | $61.91 | $81,971.75 |
DisclosureSEC source: 0001209191-21-052864 · doc4.xml · nonDerivative · entry 3 Pons Jaume · CIK 0001816977 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 481,734 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 28, 2021. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.45 to $62.44, inclusive. Read SEC document |
| August 19, 2021 Filed Aug 20, 2021 20:07 UTC |
Pons JaumeDirector · President & CEO
|
SaleCommon Stock | 4,007 | $60.78 | $243,532.64 |
DisclosureSEC source: 0001209191-21-052864 · doc4.xml · nonDerivative · entry 2 Pons Jaume · CIK 0001816977 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 483,058 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 28, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.44 to $61.43, inclusive. Read SEC document |
| August 19, 2021 Filed Aug 20, 2021 20:07 UTC |
Pons JaumeDirector · President & CEO
|
SaleCommon Stock | 7,633 | $59.79 | $456,399.97 |
DisclosureSEC source: 0001209191-21-052864 · doc4.xml · nonDerivative · entry 1 Pons Jaume · CIK 0001816977 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 487,065 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 28, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.44 to $60.435, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4) through (9) to this Form 4. F3 · balance_after: Includes 152 shares acquired under the Issuer's employee stock purchase plan on June 30, 2021. Read SEC document |
| August 17, 2021 Filed Aug 18, 2021 23:11 UTC |
GARCIA PETER SChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $4.08 | $0.00 |
DisclosureSEC source: 0001209191-21-052397 · doc4.xml · derivative · entry 7 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,289 Underlying: Common Stock · 10,000 shares Expires 2030-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option is subject to an early exercise provision and is immediately exercisable. One-fourth of the shares subject to the option vested on January 2, 2021 and 1/36th of the remaining shares vest monthly thereafter. Read SEC document |
| August 17, 2021 Filed Aug 18, 2021 23:11 UTC |
GARCIA PETER SChief Financial Officer
|
SaleCommon Stock | 40 | $68.62 | $2,744.80 |
DisclosureSEC source: 0001209191-21-052397 · doc4.xml · nonDerivative · entry 6 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,331 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021. Read SEC document |
| August 17, 2021 Filed Aug 18, 2021 23:11 UTC |
GARCIA PETER SChief Financial Officer
|
SaleCommon Stock | 2,400 | $68.34 | $164,005.20 |
DisclosureSEC source: 0001209191-21-052397 · doc4.xml · nonDerivative · entry 5 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,371 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.615 to $68.61, inclusive. Read SEC document |
| August 17, 2021 Filed Aug 18, 2021 23:11 UTC |
GARCIA PETER SChief Financial Officer
|
SaleCommon Stock | 505 | $67.13 | $33,898.98 |
DisclosureSEC source: 0001209191-21-052397 · doc4.xml · nonDerivative · entry 4 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,771 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.605 to $67.60, inclusive. Read SEC document |
| August 17, 2021 Filed Aug 18, 2021 23:11 UTC |
GARCIA PETER SChief Financial Officer
|
SaleCommon Stock | 2,368 | $65.83 | $155,892.31 |
DisclosureSEC source: 0001209191-21-052397 · doc4.xml · nonDerivative · entry 3 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,276 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.58 to $66.55, inclusive. Read SEC document |
| August 17, 2021 Filed Aug 18, 2021 23:11 UTC |
GARCIA PETER SChief Financial Officer
|
SaleCommon Stock | 4,687 | $65.24 | $305,757.38 |
DisclosureSEC source: 0001209191-21-052397 · doc4.xml · nonDerivative · entry 2 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,644 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.58 to $65.575, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (6) to this Form 4. Read SEC document |
| August 17, 2021 Filed Aug 18, 2021 23:11 UTC |
GARCIA PETER SChief Financial Officer
|
Exercise / conversionCommon Stock | 10,000 | $4.08 | $40,800.00 |
DisclosureSEC source: 0001209191-21-052397 · doc4.xml · nonDerivative · entry 1 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,331 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 203 shares acquired under the Issuer's employee stock purchase plan on June 30, 2021. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 16:11 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
SaleCommon Stock | 70 | $65.46 | $4,582.20 |
DisclosureSEC source: 0001209191-21-050823 · doc4.xml · nonDerivative · entry 3 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,202 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 28, 2021. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 16:11 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
SaleCommon Stock | 5,599 | $64.76 | $362,566.04 |
DisclosureSEC source: 0001209191-21-050823 · doc4.xml · nonDerivative · entry 2 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,272 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 28, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.42 to $65.10, inclusive. Read SEC document |
| August 10, 2021 Filed Aug 11, 2021 16:11 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
SaleCommon Stock | 1,718 | $64.20 | $110,290.62 |
DisclosureSEC source: 0001209191-21-050823 · doc4.xml · nonDerivative · entry 1 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,871 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 28, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.42 to $64.415, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| July 30, 2021 Filed Aug 3, 2021 17:22 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $58.56 | $0.00 |
DisclosureSEC source: 0001209191-21-049408 · doc4.xml · derivative · entry 1 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-07-29 F1 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 30, 2021. Read SEC document |
| July 30, 2021 Filed Aug 3, 2021 17:04 UTC |
Pons JaumeDirector · President & CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 225,000 | $0.00 Strike: $58.56 | $0.00 |
DisclosureSEC source: 0001209191-21-049385 · doc4.xml · derivative · entry 1 Pons Jaume · CIK 0001816977 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires 2031-07-29 F1 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 30, 2021. Read SEC document |
| July 30, 2021 Filed Aug 3, 2021 21:28 UTC |
Wong ShellyVP, Finance and CAO
|
GrantEmployee Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $58.56 | $0.00 |
DisclosureSEC source: 0001209191-21-049415 · doc4.xml · derivative · entry 1 Pinto Shelly · CIK 0001857740 · VP, Finance and CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2031-07-29 F1 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 30, 2021. Read SEC document |
| July 30, 2021 Filed Aug 3, 2021 21:12 UTC |
GARCIA PETER SChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $58.56 | $0.00 |
DisclosureSEC source: 0001209191-21-049398 · doc4.xml · derivative · entry 1 GARCIA PETER S · CIK 0001188956 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-07-29 F1 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on August 30, 2021. Read SEC document |
| July 19, 2021 Filed Jul 20, 2021 16:12 UTC |
Pons JaumeDirector · President & CEO
|
SaleCommon Stock | 5,900 | $55.08 | $324,983.80 |
DisclosureSEC source: 0001209191-21-047365 · doc4.xml · nonDerivative · entry 3 Pons Jaume · CIK 0001816977 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 494,546 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 28, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.03 to $55.23, inclusive. Read SEC document |
| July 19, 2021 Filed Jul 20, 2021 16:12 UTC |
Pons JaumeDirector · President & CEO
|
SaleCommon Stock | 9,500 | $54.37 | $516,553.00 |
DisclosureSEC source: 0001209191-21-047365 · doc4.xml · nonDerivative · entry 2 Pons Jaume · CIK 0001816977 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,446 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 28, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.00 to $54.95, inclusive. Read SEC document |
| July 19, 2021 Filed Jul 20, 2021 16:12 UTC |
Pons JaumeDirector · President & CEO
|
SaleCommon Stock | 1,300 | $53.62 | $69,708.21 |
DisclosureSEC source: 0001209191-21-047365 · doc4.xml · nonDerivative · entry 1 Pons Jaume · CIK 0001816977 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 509,946 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 28, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.00 to $53.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 16:50 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
SaleCommon Stock | 300 | $55.86 | $16,757.01 |
DisclosureSEC source: 0001209191-21-046679 · doc4.xml · nonDerivative · entry 2 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,589 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 28, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.71 to $56.13, inclusive. Read SEC document |
| July 12, 2021 Filed Jul 14, 2021 16:50 UTC |
Randolph SophiaDirector · Chief Medical Officer
|
SaleCommon Stock | 7,087 | $54.86 | $388,770.14 |
DisclosureSEC source: 0001209191-21-046679 · doc4.xml · nonDerivative · entry 1 Randolph Sophia · CIK 0001817127 · Director · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,889 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 28, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.58 to $55.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| June 21, 2021 Filed Jun 22, 2021 16:26 UTC |
Pons JaumeDirector · President & CEO
|
SaleCommon Stock | 10,353 | $58.92 | $609,975.98 |
DisclosureSEC source: 0001209191-21-042395 · doc4.xml · nonDerivative · entry 2 Pons Jaume · CIK 0001816977 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 511,246 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 28, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.58 to $59.22, inclusive. Read SEC document |
| June 21, 2021 Filed Jun 22, 2021 16:26 UTC |
Pons JaumeDirector · President & CEO
|
SaleCommon Stock | 6,347 | $58.06 | $368,504.28 |
DisclosureSEC source: 0001209191-21-042395 · doc4.xml · nonDerivative · entry 1 Pons Jaume · CIK 0001816977 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 521,599 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 28, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.56 to $58.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 23:03 UTC |
Graham G. WalmsleyDirector
|
GrantStock option (right to buy) · Derivative | 12,004 | $0.00 Strike: $59.66 | $0.00 |
DisclosureSEC source: 0001209191-21-040738 · doc4.xml · derivative · entry 1 Graham G. Walmsley · CIK 0001777517 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,004 Underlying: Common Stock · 12,004 shares Expires 2031-06-10 F1 · derivative.exercise_date: Shares subject to the option vest in 12 equal monthly installments on the same day of the month as the grant date, or if earlier, the day immediately before the day of the next annual meeting of stockholders. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.